The cost of potentially inappropriate medications for older adults in Canada: A comparative cross‐sectional study
While expenditures on PIMs have declined in Canada, the overall cost remains high. Prescribing of some seriously harmful classes of PIMs has increased and so directed, scalable interventions are needed.
Authors
- Justin P. Turner (ORCID: https://orcid.org/0000-0003-0613-108X)
- Camille Gagnon (ORCID: https://orcid.org/0000-0003-4576-6336)
- Emily G. McDonald (ORCID: https://orcid.org/0000-0003-0783-0624)
- Chiranjeev Sanyal (ORCID: https://orcid.org/0000-0003-3677-8036)
- Todd C. Lee (ORCID: https://orcid.org/0000-0002-2267-4239)
- Steven G. Morgan (ORCID: https://orcid.org/0000-0002-7529-0028)
- James Silvius (ORCID: https://orcid.org/0000-0001-9648-801X)
- Ninh B. Khuong (ORCID: https://orcid.org/0000-0002-4947-3306)
- Émilie Bortolussi‐Courval (ORCID: https://orcid.org/0000-0002-4926-5195)
- Jean‐François Huon (ORCID: https://orcid.org/0000-0002-8738-4419)
Institutions
- Alberta Health Services (CA)
- Dalhousie University (CA)
- University of British Columbia (CA)
- University of Calgary (CA)
- McGill University Health Centre (CA)
- Institut Universitaire de Gériatrie de Montréal (CA)
- Monash University (AU)
- Nantes Université (FR)
Publication Details
- Journal
- Journal of the American Geriatrics Society
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1111/jgs.19164
- Citations
- 26
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 8.95
Funders
- McGill University
- Canadian Frailty Network
- Canadian Institutes of Health Research